The day before 2021, the Russian Government obliged two US companies to issue licenses to their patents for Remdesivir (antiviral medication used to treat #COVID19) to the Russian #pharma company. This is the 1st time in history when the Government used this #legal opportunity under the art. 1360 of the Russian Civil Code.
On April 1, these US companies filed a claim against the Russian Government. The #court hearing will be held on May 27.